Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisy Alapat

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Histopathology|August 19, 2022
Gastrointestinal, hepatic, and pancreatobiliary involvement by plasma cell neoplasms: clinicopathologic correlations in a retrospective cohort of 116 casesJustin T Kelley, Lanisha D Fuller, Keith K Lai, et al.
Cancer|June 7, 2023
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myelomaMeera Mohan, Zimu Gong, Timothy Cody Ashby, et al.
Current Problems in Cancer. Case Reports|March 16, 2026
Breast-implant associated unicentric castleman disease: a case reportSaishravan Shyamsundar, Mateo Sarmiento Bustamante, Larissa Borys, et al.
Haematologica|January 11, 2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseMateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
Blood Advances|November 22, 2021
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myelomaMeera Mohan, Samantha Kendrick, Aniko Szabo, et al.
Blood Advances|December 5, 2023
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-upSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
Plos One|June 27, 2019
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman diseaseChristopher S Nabel, Stephen Sameroff, Dustin Shilling, et al.
Blood Advances|August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell levelCarolina Schinke, Alexandra M Poos, Michael Bauer, et al.
Haematologica|August 12, 2021
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease statusDavid Baker, Milan Bimali, Luis Carrillo, et al.
Blood Advances|September 1, 2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomesSheila K Pierson, Megan S Lim, Gordan Srkalovic, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Histopathology|August 19, 2022
Gastrointestinal, hepatic, and pancreatobiliary involvement by plasma cell neoplasms: clinicopathologic correlations in a retrospective cohort of 116 casesJustin T Kelley, Lanisha D Fuller, Keith K Lai, et al.
Cancer|June 7, 2023
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myelomaMeera Mohan, Zimu Gong, Timothy Cody Ashby, et al.
Current Problems in Cancer. Case Reports|March 16, 2026
Breast-implant associated unicentric castleman disease: a case reportSaishravan Shyamsundar, Mateo Sarmiento Bustamante, Larissa Borys, et al.
Haematologica|January 11, 2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseMateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
Blood Advances|November 22, 2021
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myelomaMeera Mohan, Samantha Kendrick, Aniko Szabo, et al.
Blood Advances|December 5, 2023
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-upSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
Plos One|June 27, 2019
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman diseaseChristopher S Nabel, Stephen Sameroff, Dustin Shilling, et al.
Blood Advances|August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell levelCarolina Schinke, Alexandra M Poos, Michael Bauer, et al.
Haematologica|August 12, 2021
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease statusDavid Baker, Milan Bimali, Luis Carrillo, et al.
Blood Advances|September 1, 2023
Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomesSheila K Pierson, Megan S Lim, Gordan Srkalovic, et al.
Pageof 4